Alexey Moiseev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexey Moiseev has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Ekaterina Tao
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Nikolay M. Bulanov
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Victoria I. Sholomova
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Viktor Viktorovich Fomin
Russian Medical Academy of Continuous Professional Education
2 shared publications - A. A. Yakovleva
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Agunda M. Kuchieva
Sechenov First Moscow State Medical University
1 shared publication
Latest Publications
- Open Access
- 5 September 2021
- Published by Pharmapress LLC in Clinical pharmacology and therapy
- Vol. 30 (3) , 43-51
Clinical manifestations and outcomes of Fabry disease in 150 adult patients
To evaluate clinical manifestations and outcomes of Fabry disease (FD) in adult patients in the Russian population.
- 5 September 2021
- Published by Pharmapress LLC in Clinical pharmacology and therapy
- Vol. 30 (3) , 43-51
Open AccessClinical manifestations and outcomes of Fabry disease in 150 adult patients
To evaluate clinical manifestations and outcomes of Fabry disease (FD) in adult patients in the Russian population.
- Open Access
- 15 November 2020
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 92 (11) , 17-23
Risk factors for the early development of septic shock in patients with severe COVID-19
Aim. In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. Materials and methods. We collected medical records of the intensive care unit patients submitted by the local COVID-19 hospitals across Russia to the Federal Center for the Critical Care at the Sechenov First Moscow State Medical University (Sechenov University). Septic shock in crticially ill patients requiring mechanical ventilation was defined as a need in vasopressors to maintain blood pressure. Results. We studied 1078 patients with severe COVID-19 who were admitted to the intensive care units for respiratory support. There were 611 males and 467 females. The mean age was 61.013.7 years. Five hundred twenty five medical records (48.7%) were received from the Moscow hospitals, 159 (14.7%) from the Moscow region, and 394 (36.5%) from the hospitals located in 58 regions of the Russian Federation. In 613 (56.9%) patients, diagnosis of SARS-CoV-2 infection was confirmed by PCR, and in the other cases it was established on the basis of the clinical picture and the results of the chest CT scan. Septic shock developed in 214 (19.9%) of 1078 patients. In the logistic regression model, the risk of septic shock in patients older than 50 years was higher than in patients of a younger age (OR 2.34; 95% CI 1.533.67; p0.0001). In patients with more severe SARS-CoV-2 infection, there was an increase in the prevalence of cardiovascular diseases, including coronary heart disease and atrial fibrillation, type 2 diabetes and malignant tumors. The risk of septic shock in patients with three or more concomitant diseases was higher than in patients without any concomitant chronic diseases (OR 1.76; 95% CI 1.762.70). Conclusion. The risk of septic shock in patients with acute respiratory distress syndrome induced by SARS-CoV-2 is higher in patients older than 50 years with concomitant diseases, although a severe course of the disease is also possible in younger patients without any concomitant disorders.
- 15 November 2020
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 92 (11) , 17-23
Open AccessRisk factors for the early development of septic shock in patients with severe COVID-19
Aim. In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. Materials and methods. We collected medical records of the intensive care unit patients submitted by the local COVID-19 hospitals across Russia to the Federal Center for the Critical Care at the Sechenov First Moscow State Medical University (Sechenov University). Septic shock in crticially ill patients requiring mechanical ventilation was defined as a need in vasopressors to maintain blood pressure. Results. We studied 1078 patients with severe COVID-19 who were admitted to the intensive care units for respiratory support. There were 611 males and 467 females. The mean age was 61.013.7 years. Five hundred twenty five medical records (48.7%) were received from the Moscow hospitals, 159 (14.7%) from the Moscow region, and 394 (36.5%) from the hospitals located in 58 regions of the Russian Federation. In 613 (56.9%) patients, diagnosis of SARS-CoV-2 infection was confirmed by PCR, and in the other cases it was established on the basis of the clinical picture and the results of the chest CT scan. Septic shock developed in 214 (19.9%) of 1078 patients. In the logistic regression model, the risk of septic shock in patients older than 50 years was higher than in patients of a younger age (OR 2.34; 95% CI 1.533.67; p0.0001). In patients with more severe SARS-CoV-2 infection, there was an increase in the prevalence of cardiovascular diseases, including coronary heart disease and atrial fibrillation, type 2 diabetes and malignant tumors. The risk of septic shock in patients with three or more concomitant diseases was higher than in patients without any concomitant chronic diseases (OR 1.76; 95% CI 1.762.70). Conclusion. The risk of septic shock in patients with acute respiratory distress syndrome induced by SARS-CoV-2 is higher in patients older than 50 years with concomitant diseases, although a severe course of the disease is also possible in younger patients without any concomitant disorders.
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , E123
Predictive Value of Cardiac MRI in Patients with Fabry Disease
- 1 August 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (2) , E123
Predictive Value of Cardiac MRI in Patients with Fabry Disease